Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Pneumaturia and Nephrotic Syndrome Caused by a HiddenPelvic Malignancy.

Li W, Sanders B, Tolwani A.

Am J Med. 2018 Oct;131(10):e421-e422. doi: 10.1016/j.amjmed.2018.05.030. Epub 2018 Jun 18. No abstract available.

PMID:
29913123
2.

Challenges of performing renal replacement therapy in the intensive care unit - The nephrologist perspective.

Cerdá J, Tolwani A, Palevsky P.

Clin Nephrol. 2018 Jul;90(1):11-17. doi: 10.5414/CN109243. No abstract available.

PMID:
29633701
3.

Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis.

Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, Myburgh J, Bouman C, Faulhaber-Walter R, Kellum JA, Palevsky PM, Ronco C, Saudan P, Tolwani A, Bellomo R.

Nephrol Dial Transplant. 2018 Jun 1;33(6):1017-1024. doi: 10.1093/ndt/gfx308.

PMID:
29186517
4.

Managing Issues in Dialysis for the Patient with AKI.

Judd E, Tolwani A.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1538-1542. doi: 10.2215/CJN.02270217. Epub 2017 Jun 21. No abstract available.

5.

Precision Continuous Renal Replacement Therapy and Solute Control.

Bagshaw SM, Chakravarthi MR, Ricci Z, Tolwani A, Neri M, De Rosa S, Kellum JA, Ronco C; ADQI Consensus Group.

Blood Purif. 2016;42(3):238-47. doi: 10.1159/000448507. Epub 2016 Aug 26.

6.

We Use Heparin as the Anticoagulant for CRRT.

Karakala N, Tolwani A.

Semin Dial. 2016 Jul;29(4):272-4. doi: 10.1111/sdi.12503. Epub 2016 Apr 15.

PMID:
27082940
7.

Efficacy and safety of 5 anesthetics in adult zebrafish (Danio rerio).

Collymore C, Tolwani A, Lieggi C, Rasmussen S.

J Am Assoc Lab Anim Sci. 2014 Mar;53(2):198-203.

8.

Association between renal replacement therapy in critically ill patients with severe acute kidney injury and mortality.

Bagshaw SM, Uchino S, Kellum JA, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Bellomo R; Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators.

J Crit Care. 2013 Dec;28(6):1011-8. doi: 10.1016/j.jcrc.2013.08.002. Epub 2013 Sep 24.

PMID:
24075302
9.

Continuous renal-replacement therapy for acute kidney injury.

Tolwani A.

N Engl J Med. 2013 Mar 21;368(12):1160-1. doi: 10.1056/NEJMc1301071. No abstract available.

10.

Continuous renal-replacement therapy for acute kidney injury.

Tolwani A.

N Engl J Med. 2012 Dec 27;367(26):2505-14. doi: 10.1056/NEJMct1206045. Review. No abstract available.

PMID:
23268665
11.

Advances in continuous renal replacement therapy: citrate anticoagulation update.

Tolwani A, Wille KM.

Blood Purif. 2012;34(2):88-93. doi: 10.1159/000342378. Epub 2012 Oct 24. Review.

PMID:
23095407
12.

Regional citrate anticoagulation for continuous renal replacement therapy: the better alternative?

Tolwani A, Wille KM.

Am J Kidney Dis. 2012 Jun;59(6):745-7. doi: 10.1053/j.ajkd.2012.03.003. No abstract available.

PMID:
22613393
13.

Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS; ADQI Workgroup.

Crit Care. 2012 Feb 9;16(1):R23. doi: 10.1186/cc11188. Review.

14.

Renal kallikrein excretion and epigenetics in human acute kidney injury: expression, mechanisms and consequences.

Kang SW, Shih PA, Mathew RO, Mahata M, Biswas N, Rao F, Yan L, Bouchard J, Malhotra R, Tolwani A, Khandrika S, Mehta RL, O'Connor DT.

BMC Nephrol. 2011 Jun 16;12:27. doi: 10.1186/1471-2369-12-27.

15.

Renal replacement therapy in special settings: extracorporeal support devices in liver failure.

Cerdá J, Tolwani A, Gibney N, Tiranathanagul K.

Semin Dial. 2011 Mar-Apr;24(2):197-202. doi: 10.1111/j.1525-139X.2011.00827.x. Review. Erratum in: Semin Dial. 2011 Jul-Aug;24(4):468.

PMID:
21517988
16.

Management of complications in renal replacement therapy.

Shingarev R, Wille K, Tolwani A.

Semin Dial. 2011 Mar-Apr;24(2):164-8. doi: 10.1111/j.1525-139X.2011.00828.x.

PMID:
21517982
17.

Development, implementation, and results of the ASN in-training examination for fellows.

Rosner MH, Berns JS, Parker M, Tolwani A, Bailey J, DiGiovanni S, Lederer E, Norby S, Plumb TJ, Qian Q, Yeun J, Hawley JL, Owens S; ASN In-Training Examination Committee.

Clin J Am Soc Nephrol. 2010 Feb;5(2):328-34. doi: 10.2215/CJN.06860909. Epub 2009 Dec 3.

18.
19.

Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study.

Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Straaten HO, Ronco C, Kellum JA.

Crit Care Med. 2009 Sep;37(9):2576-82. doi: 10.1097/CCM.0b013e3181a38241.

PMID:
19623048
20.

A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury.

Bagshaw SM, Uchino S, Cruz D, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.

Nephrol Dial Transplant. 2009 Sep;24(9):2739-44. doi: 10.1093/ndt/gfp159. Epub 2009 Apr 6.

PMID:
19349297

Supplemental Content

Loading ...
Support Center